Addition of 10-Day Decitabine to Fludarabine/Total Body Irradiation Conditioning is Feasible and Induces Tumor-Associated Antigen-Specific T Cell Responses. [electronic resource]
Producer: 20180212Description: 1000-1008 p. digitalISSN:- 1523-6536
- Adult
- Aged
- Antigens, Neoplasm -- immunology
- Antimetabolites, Antineoplastic -- administration & dosage
- Azacitidine -- administration & dosage
- CD8-Positive T-Lymphocytes -- drug effects
- Decitabine
- Female
- Graft vs Host Disease
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Leukemia, Myeloid, Acute -- mortality
- Leukemia, Myelomonocytic, Chronic -- mortality
- Male
- Middle Aged
- Myelodysplastic Syndromes -- mortality
- Survival Analysis
- Transplantation Conditioning -- adverse effects
- Transplantation, Homologous
- Vidarabine -- administration & dosage
- Whole-Body Irradiation
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.